These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1606787)

  • 1. Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).
    Ponto LL; Ponto JA
    Clin Pharmacokinet; 1992 Apr; 22(4):274-83. PubMed ID: 1606787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part I).
    Ponto LL; Ponto JA
    Clin Pharmacokinet; 1992 Mar; 22(3):211-22. PubMed ID: 1559312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Positron emission tomography in pharmacokinetics and pharmacodynamics].
    Lucignani G; Moresco RM; Fazio F
    Boll Chim Farm; 1993; 132(7):231-3. PubMed ID: 8398055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-animal PET: a promising, non-invasive tool in pre-clinical research.
    Schnöckel U; Hermann S; Stegger L; Law M; Kuhlmann M; Schober O; Schäfers K; Schäfers M
    Eur J Pharm Biopharm; 2010 Jan; 74(1):50-4. PubMed ID: 19482080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in drug development.
    Rubin RH; Fischman AJ
    Q J Nucl Med; 1997 Jun; 41(2):171-5. PubMed ID: 9203856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging of cancer with positron emission tomography.
    Gambhir SS
    Nat Rev Cancer; 2002 Sep; 2(9):683-93. PubMed ID: 12209157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New techniques in the pharmacokinetic analysis of cancer drugs. IV. Positron emission tomography.
    Tilsley DW; Harte RJ; Jones T; Brady F; Luthra SK; Brown G; Price PM
    Cancer Surv; 1993; 17():425-42. PubMed ID: 8137352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Instrumentation in positron emission tomography. Council on Scientific Affairs. Report of the Positron Emission Tomography Panel.
    JAMA; 1988 Mar; 259(10):1531-6. PubMed ID: 3257530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positron emission tomography instrumentation: an overview.
    Volkow ND; Mullani NA; Bendriem B
    Am J Physiol Imaging; 1988; 3(3):142-53. PubMed ID: 3056465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography in cardiovascular disease.
    Beanlands R
    Can J Cardiol; 1996 Oct; 12(10):875-83. PubMed ID: 9191475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography for use in microdosing studies.
    Wagner CC; Müller M; Lappin G; Langer O
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Applications of positron emission tomography (PET) to the measurement of regional cerebral pharmacokinetics].
    Stöcklin G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1992 Apr; 27(2):84-92. PubMed ID: 1356493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.
    van Hoogdalem EJ; de Boer AG; Breimer DD
    Clin Pharmacokinet; 1991 Aug; 21(2):110-28. PubMed ID: 1884566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography. Biomedical research and clinical application.
    Wolf AP; Fowler JS
    Neuroimaging Clin N Am; 1995 Feb; 5(1):87-101. PubMed ID: 7743087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles and clinical applications of positron emission tomography.
    Gardner SF; Green JA; Bednarczyk EM; Farnett L; Miraldi F
    Am J Hosp Pharm; 1992 Jun; 49(6):1499-506. PubMed ID: 1530002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography in assessment of regional stereospecificity of drugs.
    Wagner HN
    Biochem Pharmacol; 1988 Jan; 37(1):51-9. PubMed ID: 3276318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticancer activity using positron emission tomography-computed tomography and pharmacokinetics of β-eudesmol in human cholangiocarcinoma xenografted nude mouse model.
    Plengsuriyakarn T; Karbwang J; Na-Bangchang K
    Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):293-304. PubMed ID: 25545782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography.
    Dollé F
    J Labelled Comp Radiopharm; 2013; 56(3-4):65-7. PubMed ID: 24285311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging opiate receptors in the human brain with positron emission tomography. Potential applications for drug addiction research.
    Sadzot B; Mayberg HS; Frost JJ
    Acta Psychiatr Belg; 1990; 90(1):9-19. PubMed ID: 1670391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
    Bruschini P; Giorgetti A; Bruschini L; Nacci A; Volterrani D; Cosottini M; Ursino F; Mariani G; Fattori B
    Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):446-53. PubMed ID: 15198047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.